FDA approves Zika-fighting genetically modified mosquito for trial

August 6, 2016 10:00 AM

31 0

After months of reviewing public comments to its draft environmental impact study, the Food and Drug Administration announced today that it is officially giving OX513A, a genetically modified male mosquito developed by British company, Oxitec, a clean bill of health. The decision gives the federal green light for the use of the mosquito in a field trial this fall in a small Florida neighborhood.

"We're really pleased to announce the FDA finished their review and has found no significant impact of the release of our mosquito on human health or the environment," Oxitec CEO Hadyn Parry said. "This is especially timely, given the recent finding of Zika transmission by local mosquitoes in a Miam...

Also read: Florida’s Senate Candidates Vie for Puerto Rican Vote

Read more

To category page